Qiagen N.V. (QGEN) Issues FY13 Earnings Guidance
Qiagen N.V. (NASDAQ:QGEN) issued an update on its FY13 earnings guidance on Tuesday morning. The company provided EPS guidance of $1.13 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.11, AnalystRatingsNetwork.com reports. The company issued revenue guidance of $1.32 billion, compared to the consensus revenue estimate of $1.31 billion.Qiagen N.V. also updated its Q4 guidance to $0.35 EPS.
Shares of Qiagen N.V. (NASDAQ:QGEN) traded up 0.14% on Tuesday, hitting $21.92. The stock had a trading volume of 761,470 shares. Qiagen N.V. has a 52 week low of $16.98 and a 52 week high of $22.20. The stock’s 50-day moving average is $20.98 and its 200-day moving average is $20.21. The company has a market cap of $5.137 billion and a P/E ratio of 148.91.
Qiagen N.V. (NASDAQ:QGEN) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.03. The company had revenue of $323.80 million for the quarter, compared to the consensus estimate of $320.37 million. During the same quarter in the previous year, the company posted $0.26 earnings per share. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. Analysts expect that Qiagen N.V. will post $1.03 EPS for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at TheStreet downgraded shares of Qiagen N.V. from a buy rating to a hold rating in a research note to investors on Tuesday. Three analysts have rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $21.58.
QIAGEN N.V., (NASDAQ:QGEN) is a holding company, which provides sample and assay technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.